{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:50:49Z","timestamp":1792651849658,"version":"4.5.0"},"reference-count":63,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM114737"],"award-info":[{"award-number":["P30GM114737"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.01571","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T03:54:30Z","timestamp":1502942070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4"],"prefix":"10.3389","volume":"8","author":[{"given":"Chih-Yun","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri Ann S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel T.","family":"Lehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Verma","given":"Saguna","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0118345","DOI":"10.1371\/journal.pone.0118345","article-title":"Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection","volume":"10","author":"Ayithan","year":"2015","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jir.2013.0035","article-title":"Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways","volume":"34","author":"Ayithan","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B5","first-page":"25","article-title":"Postexposure prophylaxis for common infectious diseases","volume":"88","author":"Bader","year":"2013","journal-title":"Amer. Family Phys."},{"key":"B6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.3390\/v7102892","article-title":"The role of cytokines and chemokines in filovirus infection","volume":"7","author":"Bixler","year":"2015","journal-title":"Viruses"},{"key":"B8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.virol.2004.05.025","article-title":"Ebola and Marburg virus-like particles activate human myeloid dendritic cells","volume":"326","author":"Bosio","year":"2004","journal-title":"Virology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0118434","DOI":"10.1371\/journal.pone.0118434","article-title":"Mechanisms of immunity in post-exposure vaccination against Ebola virus infection","volume":"10","author":"Bradfute","year":"2015","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/v4091477","article-title":"Mouse models for filovirus infections","volume":"4","author":"Bradfute","year":"2012","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.15585\/mmwr.su6503a4","article-title":"Early identification and prevention of the spread of ebola in high-risk African countries","volume":"65","author":"Breakwell","year":"2016","journal-title":"MMWR Suppl."},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1086\/514305","article-title":"Pathogenesis of experimental Ebola virus infection in guinea pigs","volume":"179","author":"Connolly","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fimmu.2013.00214","article-title":"Vaccine adjuvants: mode of action","volume":"4","author":"De Gregorio","year":"2013","journal-title":"Front. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","article-title":"Ectodomain shedding of the glycoprotein GP of Ebola virus","volume":"23","author":"Dolnik","year":"2004","journal-title":"EMBO J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1004509","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-Perez","year":"2014","journal-title":"PLoS Pathog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"B21","first-page":"923","article-title":"Filoviridae: Marburg and Ebola Viruses","volume-title":"Fields Virology 6th Edn.","author":"Feldmann","year":"2013"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3201\/eid1607.100159","article-title":"Postexposure treatment of Marburg virus infection","volume":"16","author":"Geisbert","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"","journal-title":"Amer. J. Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"","journal-title":"Amer. J. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol. Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1006397","DOI":"10.1371\/journal.ppat.1006397","article-title":"Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection","volume":"13","author":"Iampietro","year":"2017","journal-title":"PLoS Pathog."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","article-title":"Covalent modifications of the ebola virus glycoprotein","volume":"76","author":"Jeffers","year":"2002","journal-title":"J. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/JVI.02667-12","article-title":"Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis","volume":"87","author":"Kumar","year":"2013","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.068","article-title":"Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice","author":"Lehrer","year":"2017","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2249.2001.01517.x","article-title":"Early immune responses accompanying human asymptomatic Ebola infections","volume":"124","author":"Leroy","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/S0140-6736(00)02405-3","article-title":"Human asymptomatic Ebola infection and strong inflammatory response","volume":"355","author":"Leroy","year":"2000","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1128\/JVI.03316-12","article-title":"The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains","volume":"87","author":"Lubaki","year":"2013","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/14760584.2016.1187566","article-title":"Ebola virus disease candidate vaccines under evaluation in clinical trials","volume":"15","author":"Martins","year":"2016","journal-title":"Exp. Rev. Vaccines"},{"key":"B40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1086\/378357","article-title":"Effectiveness of postexposure vaccination for the prevention of smallpox: results of a delphi analysis","volume":"188","author":"Massoudi","year":"2003","journal-title":"J. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"304r","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.virusres.2015.10.021","article-title":"Recent advances in the development of vaccines for Ebola virus disease","volume":"211","author":"Ohimain","year":"2016","journal-title":"Virus Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1128\/JVI.01462-09","article-title":"Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1","volume":"84","author":"Okumura","year":"2010","journal-title":"J. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"199r","DOI":"10.1126\/scitranslmed.3006608","article-title":"Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail","volume":"5","author":"Pettitt","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","article-title":"Targeting dendritic cells with biomaterials: developing the next generation of vaccines","volume":"27","author":"Reddy","year":"2006","journal-title":"Trends Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice. Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and activation of monocytes by Marburg and Ebola viruses","volume":"75","author":"Stroher","year":"2001","journal-title":"J. Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/14760584.7.4.417","article-title":"Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses","volume":"7","author":"Swenson","year":"2008","journal-title":"Exp. Rev. Vaccines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fmicb.2012.00034","article-title":"Filovirus tropism: cellular molecules for viral entry","volume":"3","author":"Takada","year":"2012","journal-title":"Front. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.vaccine.2006.09.076","article-title":"Protective efficacy of neutralizing antibodies against Ebola virus infection","volume":"25","author":"Takada","year":"2007","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jcv.2016.11.005","article-title":"Ebola virus disease: an update on current prevention and management strategies","volume":"86","author":"Trad","year":"2017","journal-title":"J. Clin. Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for ebola virus disease in guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.virol.2009.10.036","article-title":"Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor","volume":"397","author":"Verma","year":"2010","journal-title":"Virology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1359","DOI":"10.1371\/journal.pntd.0001359","article-title":"Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression","volume":"5","author":"Wahl-Jensen","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1128\/JVI.79.4.2413-2419.2005","article-title":"Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages","volume":"79","author":"Wahl-Jensen","year":"2005","journal-title":"J. Virol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B59","doi-asserted-by":"publisher","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot5080","article-title":"Bone marrow-derived macrophages (BMM): isolation and applications","author":"Weischenfeldt","year":"2008","journal-title":"CSH Protoc"},{"key":"B62","volume-title":"Ebola Situation Report-11 May 2016","year":"2016"},{"key":"B63","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1086\/514319","article-title":"A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Zaki","year":"1999","journal-title":"J. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.01571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T03:54:33Z","timestamp":1502942073000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.01571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":63,"alternative-id":["10.3389\/fmicb.2017.01571"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.01571","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"article-number":"1571"}}